Periodontitis and Diabetes Mellitus

Periodontitis and diabetes mellitus are linked in what is widely described as a two-way relationship: diabetes, particularly when poorly controlled, increases the risk and severity of periodontitis, and periodontitis is in turn associated with poorer glycaemic control. This bidirectional association is among the better-supported periodontal-systemic links and is the subject of joint consensus guidance from periodontology and diabetes bodies.

Definition

The periodontitis-diabetes relationship is a bidirectional association in which diabetes mellitus predisposes to and worsens periodontitis, while periodontitis is associated with adverse effects on glycaemic control and diabetes complications.

Scope

This topic covers both directions of the periodontitis-diabetes relationship, the inflammatory and metabolic mechanisms thought to underlie it, and the consensus evidence that distinguishes well-supported associations from areas of remaining uncertainty. It is reference material on the relationship and does not provide individual management of either condition.

Core questions

• How does diabetes increase susceptibility to and severity of periodontitis?
• By what mechanisms might periodontitis affect glycaemic control?
• What does the evidence show about periodontal treatment and HbA1c?
• Why is this relationship described as bidirectional?

Key concepts

• Two-way (bidirectional) relationship
• Glycaemic control and HbA1c
• Advanced glycation end-products (AGEs) and RAGE
• Hyperinflammatory response
• Insulin resistance and systemic inflammation
• Diabetes complications

Mechanisms

In the diabetes-to-periodontitis direction, sustained hyperglycaemia promotes formation of advanced glycation end-products that, through their receptor RAGE, amplify inflammatory responses, impair wound healing, and alter immune-cell and connective-tissue function, increasing periodontal tissue destruction. In the periodontitis-to-diabetes direction, the systemic inflammatory burden from periodontal infection, including elevated cytokines, is proposed to contribute to insulin resistance and worsen glycaemic control. Preshaw et al. (2012) articulate this two-way model, and Hajishengallis and Chavakis (2021) situate it within the general inflammatory linkage between periodontitis and metabolic comorbidities.

Clinical relevance

The periodontitis-diabetes relationship is a frequently cited example of how an oral disease interfaces with a major systemic condition, and joint professional bodies have produced guidance reflecting it. The material here characterises the relationship and its evidence base at a conceptual level; it is not individualised advice for managing diabetes or periodontitis, which requires professional assessment.

Epidemiology

Diabetes is an established risk factor for periodontitis, with people who have poorly controlled diabetes showing higher prevalence and severity, and periodontitis is correspondingly common among people with diabetes. In the reverse direction, observational evidence links periodontitis to poorer glycaemic control and to a higher incidence of diabetes complications. The IDF/EFP consensus summarised this epidemiology and graded the strength of evidence for each direction (Sanz et al., 2018).

Evidence & guidelines

The joint workshop of the International Diabetes Federation and the European Federation of Periodontology produced a consensus report and guidelines synthesising the evidence (Sanz et al., 2018). It supports diabetes as a risk factor for periodontitis and reports that periodontal therapy is associated with modest improvements in glycaemic control in people with type 2 diabetes, while noting variability across studies and the need for cautious interpretation. Preshaw et al. (2012) provide the widely cited narrative framing of the bidirectional model.

History

The link between diabetes and periodontal disease has long been recognised clinically, with periodontitis sometimes described as a complication of diabetes. From the 1990s onward, the field of periodontal medicine reframed it as a two-way relationship, supported by accumulating epidemiological and mechanistic work. This culminated in joint guidance from the diabetes and periodontology communities, notably the 2018 IDF/EFP consensus report, which formalised the bidirectional view and its evidence base.

Debates

How much does periodontal treatment improve glycaemic control?

Meta-analyses suggest periodontal therapy is associated with a modest reduction in HbA1c in people with type 2 diabetes, but the magnitude and durability of the effect, and its clinical importance, are debated and vary across trials.

Key figures

• Philip Preshaw
• Mariano Sanz
• Iain Chapple
• George Hajishengallis

Seminal works

• preshaw-2012
• sanz-2018

Frequently asked questions

Why is the link between diabetes and gum disease called a two-way relationship?

Diabetes, especially when poorly controlled, increases the risk and severity of periodontitis, and periodontitis is in turn associated with poorer blood-sugar control, so each condition can adversely affect the other.

Can treating gum disease improve blood-sugar control in diabetes?

Evidence summarised in consensus guidance suggests periodontal treatment is associated with modest improvements in glycaemic control in people with type 2 diabetes, but the effect varies between studies and this is reference information rather than individual medical advice.